G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,590 | -67.9% | 10,132 | -44.5% | 0.00% | – |
| Q2 2023 | $45,439 | -99.1% | 18,248 | -99.1% | 0.00% | – |
| Q1 2023 | $5,170,214 | +241.8% | 1,929,184 | +592.5% | 0.00% | – |
| Q4 2022 | $1,512,619 | -75.8% | 278,567 | -44.3% | 0.00% | -100.0% |
| Q3 2022 | $6,242,000 | +158.6% | 499,728 | +2.3% | 0.00% | – |
| Q2 2022 | $2,414,000 | -34.9% | 488,707 | +0.2% | 0.00% | – |
| Q1 2022 | $3,707,000 | +229.5% | 487,725 | +342.8% | 0.00% | – |
| Q4 2021 | $1,125,000 | -89.5% | 110,139 | -86.2% | 0.00% | -100.0% |
| Q3 2021 | $10,713,000 | -40.0% | 798,300 | -1.9% | 0.00% | 0.0% |
| Q2 2021 | $17,851,000 | -8.8% | 813,641 | +0.0% | 0.00% | -50.0% |
| Q1 2021 | $19,575,000 | +17.8% | 813,600 | -11.9% | 0.00% | +100.0% |
| Q4 2020 | $16,622,000 | -66.5% | 923,939 | -78.5% | 0.00% | -80.0% |
| Q3 2020 | $49,546,000 | -63.9% | 4,289,691 | -24.2% | 0.01% | -66.7% |
| Q2 2020 | $137,326,000 | +120.7% | 5,660,589 | +0.3% | 0.02% | +66.7% |
| Q1 2020 | $62,223,000 | -58.2% | 5,646,329 | +0.2% | 0.01% | -43.8% |
| Q4 2019 | $148,992,000 | +16.2% | 5,637,226 | +0.2% | 0.02% | +6.7% |
| Q3 2019 | $128,215,000 | -25.6% | 5,628,388 | +0.1% | 0.02% | -25.0% |
| Q2 2019 | $172,311,000 | +85.0% | 5,620,072 | +0.2% | 0.02% | +81.8% |
| Q1 2019 | $93,147,000 | -12.8% | 5,611,235 | +0.6% | 0.01% | -26.7% |
| Q4 2018 | $106,814,000 | -60.8% | 5,577,754 | +6.9% | 0.02% | -51.6% |
| Q3 2018 | $272,780,000 | +28.0% | 5,216,663 | +6.4% | 0.03% | +24.0% |
| Q2 2018 | $213,073,000 | +18.7% | 4,902,732 | +1.2% | 0.02% | +19.0% |
| Q1 2018 | $179,529,000 | +120.3% | 4,845,576 | +18.0% | 0.02% | +110.0% |
| Q4 2017 | $81,476,000 | +29.8% | 4,106,644 | +62.8% | 0.01% | +25.0% |
| Q3 2017 | $62,773,000 | +84.1% | 2,522,033 | +29.0% | 0.01% | +100.0% |
| Q2 2017 | $34,093,000 | – | 1,954,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |